Stock Analiz

CytomX Therapeutics, Inc. (CTMX) stock forecast and price target

Price $2.04 · data as of November 13, 2026

12-month price target

Average target$12.38
Upside / downside+506.6%
Analysts8
ConsensusStrong buy
Low $5.00Average $12.38High $16.00

Gold marker: average target · white marker: today’s price ($2.04)

Analyst ratings

Strong buy 3Buy 5Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.39−158.2%$22M
Next fiscal year
ends December 31, 2027
$-0.50−28.7%$26M
Next quarter
ends December 31, 2026
$-0.08+62.7%$10M
Quarter after
ends March 31, 2027
$-0.10−1.6%$5M

Consensus of the analysts covering CytomX Therapeutics, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.

Frequently asked questions

What is the CytomX Therapeutics stock price target?

The average 12-month target from 8 analysts is $12.38, 506.6% above the current price of $2.04 Targets range from $5.00 to $16.00.

Is CytomX Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (3 strong buy, 5 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is CytomX Therapeutics expected to earn?

Analysts expect EPS of $-0.39 for the fiscal year ending December 31, 2026 and $-0.50 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.